Entasis Therapeutics Holdings
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
INNOVIVA, INC. other
 Common Stock 7,598,814 $2.2 $16,717,391
Sale
PERROS MANOUSSOS director, officer: President an..
 Common Stock 11,974 $3.19 $38,197
Sale
GUTCH MICHAEL officer: Chief Financial Office..
 Common Stock 3,759 $3.19 $11,991
Sale
MUELLER JOHN PATRICK officer: Chief Development Offi..
 Common Stock 4,001 $3.19 $12,763
Sale
KEILEY ELIZABETH M officer: General Counsel
 Common Stock 3,759 $3.19 $11,991
Sale
TOMMASI RUBEN officer: Chief Scientific Officer
 Common Stock 3,759 $3.19 $11,991
Sale
RONSHEIM MATTHEW officer: Chief of Pharmaceutica..
 Common Stock 3,759 $3.19 $11,991
Sale
ALTARAC DAVID officer: Chief Medical Officer
 Common Stock 3,759 $3.19 $11,991
Purchase
INNOVIVA, INC. 10 percent owner
 Common Stock 6,268,975 N/A N/A
Purchase
INNOVIVA, INC. 10 percent owner
 Common Stock 3,731,025 N/A N/A
Purchase
INNOVIVA, INC. 10 percent owner
 Common Stock 4,672,897 $2.68 $12,499,999
Purchase
INNOVIVA, INC. 10 percent owner
 Common Stock 12,677,490 $2.5 $31,693,725
Sale
FRAZIER LIFE SCIENCES VIII, L.P. 10 percent owner
 Common Stock 50,000 $5 $250,000
Option
TOMMASI RUBEN officer: Chief Scientific Officer
 Common Stock 22,024 N/A N/A
Option
TOMMASI RUBEN officer: Chief Scientific Officer
 Employee Stock Option (Right to Buy) 22,024 $3.43 $75,432
Option
TOMMASI RUBEN officer: Chief Scientific Officer
 Common Stock 22,024 $3.43 $75,432
Option
TOMMASI RUBEN officer: Chief Scientific Officer
 Employee Stock Option (Right to Buy) 22,024 $3.43 $75,432
Purchase
GALAKATOS NICHOLAS director
 Common Stock 453,395 $15 $6,800,925
Purchase
PIVOTAL BIOVENTURE PARTNERS FUND I, L.P. 10 percent owner
 Common Stock 337,724 $15 $5,065,860
Purchase
PRESTON HEATHER director
 Common Stock 337,724 $15 $5,065,860
Purchase
SOFINNOVA VENTURE PARTNERS IX, L.P. 10 percent owner
 Common Stock 337,724 $15 $5,065,860
Purchase
TOPPER JAMES N 10 percent owner
 Common Stock 375,887 $15 $5,638,305
Purchase
TPG GROUP HOLDINGS (SBS) ADVISORS, INC. other: Former 10% Owner
 Common Stock 262,539 N/A N/A
Purchase
ASTRAZENECA PLC 10 percent owner
 Common Stock 246,666 N/A N/A
Purchase
NOVO HOLDINGS A/S 10 percent owner
 Common Stock 1,089,835 N/A N/A
Purchase
CLARUS LIFESCIENCES III, L.P. 10 percent owner
 Common Stock 453,395 N/A N/A
Purchase
FRAZIER LIFE SCIENCES VIII, L.P. 10 percent owner
 Common Stock 375,887 N/A N/A

Showing 1 to 27 of 27 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: